We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. CooperVision and EssilorLuxottica announced the official ...
To learn more about this innovation and CooperVision's evidence-based myopia management portfolio, visit www.coopervision.co.uk. About CooperVisionCooperVision, a division of CooperCompanies (Nasdaq: ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. ATLANTA — CooperVision announced the U.S. and global ...
SAN RAMON, Calif., Nov. 18, 2019 /PRNewswire/ -- CooperVision announced today it has received U.S. Food and Drug Administration (FDA) approval of its innovative MiSight® 1 day contact lens1. The ...
SAN RAMON, Calif., Oct. 9, 2020 /PRNewswire/ -- CooperVision is reporting the latest findings from its landmark MiSight® 1 day clinical study, providing new insights about myopia management and the ...
SAN RAMON, CALIF., March 10, 2022—A new peer review paper affirms that CooperVision ® MiSight ® 1 day contact lenses provide myopia control for nearly all children. †1 In the longest-running soft ...
At the International Myopia Conference, CooperVision will offer new insights into the treatment efficacy of the fastest growing eyes fit with MiSight® 1 day contact lenses, derived from the world’s ...
That’s a simple statement, but it masks an enormous amount of complexity most people just don’t think about. We take so much about contact lenses for granted: their safety, their availability, the ...
MiSight ® 1 day will launch in the U.S. as part of a CooperVision myopia management initiative beginning in March 2020. The lens is already being successfully worn by thousands of myopic children in ...
New Lenses Combine Advanced Silicone Hydrogel Material with Proven ActivControl Technology *1 to Slow the Worsening of Myopia in Children †2,3 FAREHAM, England, Jan. 6, 2026 /PRNewswire/ -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results